Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Pharmacology, Medicine, Rheumatoid arthritis, KEGG, Systems pharmacology, and Luteolin.
Brevilin A, a novel LRRC15 inhibitor, exerts potent anti-rheumatoid arthritis effects by inhibiting the LRRC15/STAT3 signaling pathway
Therapeutic effects of Siegesbeckia orientalis L. and its active compound luteolin in rheumatoid arthritis: network pharmacology, molecular docking and experimental validation
Centipeda minima: An update on its phytochemistry, pharmacology and safety
Metabolomics Reveals the Mechanisms for the Pulmonary Toxicity of Siegesbeckia orientalis L. and the Toxicity-Reducing Effect of Processing